We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$4.36B
AUM Growth
+$383M
Cap. Flow
+$147M
Cap. Flow %
3.36%
Top 10 Hldgs %
66.22%
Holding
647
New
80
Increased
282
Reduced
189
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 4.43%
2 Financials 2.12%
3 Healthcare 2.11%
4 Consumer Discretionary 1.32%
5 Communication Services 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGK icon
101
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
$2.64M 0.06%
55,990
-675
-1% -$29.1K
DFUS
102
Dimensional US Equity ETF
DFUS
$20.8B
$2.63M 0.06%
54,670
LIT icon
103
Global X Lithium & Battery Tech ETF
LIT
$1.51B
$2.59M 0.06%
39,800
-155
-0.4% -$9.66K
BMY icon
104
Bristol-Myers Squibb
BMY
$133B
$2.57M 0.06%
40,216
+8,344
+26% +$560K
NEE icon
105
NextEra Energy
NEE
$181B
$2.45M 0.06%
33,017
-731
-2% -$55.3K
ORCL icon
106
Oracle
ORCL
$374B
$2.45M 0.06%
20,568
-549
-3% -$56.8K
ADI icon
107
Analog Devices
ADI
$179B
$2.45M 0.06%
12,569
-375
-3% -$69.4K
VSS icon
108
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$2.41M 0.06%
21,786
-744
-3% -$82K
CRM icon
109
Salesforce
CRM
$151B
$2.41M 0.06%
11,393
-96
-0.8% -$19.6K
DE icon
110
Deere & Co
DE
$160B
$2.4M 0.06%
5,914
+115
+2% +$44K
ACWX icon
111
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$2.36M 0.05%
47,960
XBI icon
112
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$2.28M 0.05%
27,349
-23,231
-46% -$1.94M
AXP icon
113
American Express
AXP
$227B
$2.27M 0.05%
13,049
-1,121
-8% -$181K
VDC icon
114
Vanguard Consumer Staples ETF
VDC
$7.97B
$2.27M 0.05%
11,656
LOW icon
115
Lowe's Companies
LOW
$117B
$2.23M 0.05%
9,896
+1,337
+16% +$278K
VOT icon
116
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$2.22M 0.05%
10,796
-1,137
-10% -$220K
RTX icon
117
RTX Corp
RTX
$290B
$2.22M 0.05%
22,628
-6,693
-23% -$655K
UNP icon
118
Union Pacific
UNP
$174B
$2.2M 0.05%
10,752
+460
+4% +$91.4K
BAC icon
119
Bank of America
BAC
$435B
$2.13M 0.05%
74,190
-743
-1% -$21.2K
TSM icon
120
TSMC
TSM
$2.1T
$2.06M 0.05%
20,450
+6,661
+48% +$620K
GL icon
121
Globe Life
GL
$14.2B
$2.03M 0.05%
18,507
-1,706
-8% -$183K
QCOM icon
122
Qualcomm
QCOM
$155B
$2.01M 0.05%
16,917
-12,409
-42% -$1.43M
ITW icon
123
Illinois Tool Works
ITW
$82.6B
$2.01M 0.05%
8,039
-1,256
-14% -$294K
SBUX icon
124
Starbucks
SBUX
$120B
$2.01M 0.05%
20,283
-373
-2% -$38.7K
APD icon
125
Air Products & Chemicals
APD
$65.7B
$2M 0.05%
6,686
-199
-3% -$56.7K

Similar funds

Ballentine Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Ballentine Partners held 647 positions worth $4.36B, up 9.6% from $3.97B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Ballentine Partners deployed $147M of net new capital in Q2 2023, opening 80 new positions and adding to 282 existing holdings. Its largest new stake was EA Bridgeway Omni Small-Cap Value ETF: 50,537 shares worth $901K.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 4.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Goldman Sachs JUST US Large Cap Equity ETF, an estimated $3.48M trimmed.

  • Ballentine Partners's largest Q2 2023 buy was EA Bridgeway Omni Small-Cap Value ETF: 50,537 shares worth $901K.
  • Ballentine Partners added most to Vanguard Real Estate ETF in Q2 2023, an estimated $54.3M increase.
  • Ballentine Partners's biggest Q2 2023 reduction was Goldman Sachs JUST US Large Cap Equity ETF, cutting an estimated $3.48M.
  • Ballentine Partners fully exited Harbor Dividend Growth Leaders ETF in Q2 2023, selling an estimated $4.65M.
  • Ballentine Partners's ten largest holdings make up 66% of its $4.36B portfolio in Q2 2023.
  • Ballentine Partners opened 80 new positions and closed 46 in Q2 2023.
  • Ballentine Partners's portfolio value rose 9.6% quarter-over-quarter to $4.36B.

Based on Ballentine Partners's 13F filing for Q2 2023, filed 26 Jul 2023.